Abbott and Idera sign agreement to develop compani..

created a new article

Translate 3 months ago

Abbott and Idera sign agreement to develop companion diagnostic for B-cell lymphoma | #b Cell Non Hodgkins Lymphoma Market

Abbott and Idera sign agreement to develop companion diagnostic for B-cell lymphoma

Idera Pharmaceuticals has entered into an agreement with Abbott to develop an in-vitro companion diagnostic test for use in Idera's clinical development programmes to treat certain genetically defined forms of B-cell lymphoma with its lead drug candidate IMO-8400.

Abbott and Idera sign agreement to develop companion diagnostic for B-cell lymphoma

Like

Comment

Share

640